78 related articles for article (PubMed ID: 2097268)
1. Prognosis in Hodgkin's disease: verification of a new predictive equation.
Bettini R; Quadrelli M; Quadrelli G; Biganzoli L; Venco A
Haematologica; 1990; 75(5):482. PubMed ID: 2097268
[No Abstract] [Full Text] [Related]
2. Prognostic significance of serum albumin in Hodgkin's disease.
Gobbi PG; Cavalli C; Gendarini A; Bonfichi M; Galeone F; Inzoli A; Ascari E
Haematologica; 1986; 71(2):95-102. PubMed ID: 3087839
[No Abstract] [Full Text] [Related]
3. Verification and comparison of two different predictive equations in Hodgkin's disease.
Bettini R; Tonolini M; Maccianti E
Haematologica; 1997; 82(3):324-7. PubMed ID: 9234580
[TBL] [Abstract][Full Text] [Related]
4. [Serum protein pattern in patients with Hodgkin's disease].
Glińska H; Adamczyk B
Pol Tyg Lek; 1969 Jun; 24(26):993-5. PubMed ID: 5805072
[No Abstract] [Full Text] [Related]
5. Multivariate analysis of Hodgkin's disease prognosis. Fitness and use of a directly predictive equation.
Gobbi PG; Gobbi PG; Mazza P; Zinzani PL
Haematologica; 1989; 74(1):29-38. PubMed ID: 2498180
[TBL] [Abstract][Full Text] [Related]
6. [Prognosis in Hodgkin's disease: verification of a new predictive equation].
Bettini R; Quadrelli G; Quadrelli CM; Biganzoli L; Venco A
Recenti Prog Med; 1990 Sep; 81(9):579-80. PubMed ID: 2263753
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease prognosis: a directly predictive equation.
Gobbi PG; Cavalli C; Federico M; Bertoloni D; Di Prisco UA; Rossi A; Silingardi V; Mauri C; Ascari E
Lancet; 1988 Mar; 1(8587):675-9. PubMed ID: 2895213
[TBL] [Abstract][Full Text] [Related]
8. [Disk electrophoresis, on polyacrylamide gel. II. Variability of serum "patterns" of patients with Hodgkin's disease as compared with those of normal individuals].
Sega E; Minetti M; Petrucci T
Boll Ist Sieroter Milan; 1973; 52(3):242-6. PubMed ID: 4762781
[No Abstract] [Full Text] [Related]
9. Ceruloplasmin in Hodgkin's disease.
Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
[TBL] [Abstract][Full Text] [Related]
10. [Behavior of the leukocyte sedimentation rate in malignant neoplasms, Hodgkin's disease and lympho-reticulosarcoma].
Colantuono A; Maccauro L
Rass Int Clin Ter; 1967 May; 47(9):491-504. PubMed ID: 4887990
[No Abstract] [Full Text] [Related]
11. [Assessment of the histologic type of Hodgkin's disease as a prognostic factor].
Shust VF; Markochev AB; Skripkina NS
Vopr Onkol; 1989; 35(10):1251-4. PubMed ID: 2596072
[TBL] [Abstract][Full Text] [Related]
12. [Hodgkin's disease: clinical and hematological findings].
Hofmann V; Berchtold H; Martz G
Schweiz Med Wochenschr; 1974 Feb; 104(6):204-8. PubMed ID: 4811567
[No Abstract] [Full Text] [Related]
13. Invited discussion: Approaches to the serologic characterization of Hodgkin's disease.
Sega E; Isabella F; Minnetti M; Petrucci T; Citro G
Natl Cancer Inst Monogr; 1973 May; 36():159-62. PubMed ID: 4200712
[No Abstract] [Full Text] [Related]
14. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
[TBL] [Abstract][Full Text] [Related]
15. Survival after recurrence: prognostic factors and spread patterns in clinical stages I and II of Hodgkin's disease.
Tubiana M; van der Werf-Messing B; Laugier A; Hayat M; Henry-Amar M; Attie E; Leroy T
Natl Cancer Inst Monogr; 1973 May; 36():513-30. PubMed ID: 4744607
[No Abstract] [Full Text] [Related]
16. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
[TBL] [Abstract][Full Text] [Related]
17. Value of laboratory indicators in Hodgkin's disease: preliminary results.
Ray GR; Wolf PH; Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
[No Abstract] [Full Text] [Related]
18. Systemic disturbance in Hodgkin's disease and its relation to histopathology and prognosis (BNLI report No. 30).
Vaughan Hudson B; Maclennan KA; Bennett MH; Easterling MJ; Vaughan Hudson G; Jelliffe AM
Clin Radiol; 1987 May; 38(3):257-61. PubMed ID: 3581667
[TBL] [Abstract][Full Text] [Related]
19. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
